Accelerating Bioconjugate Development From Discovery to Commercialisation With WuXi XDC’s Fully Integrated Capabilities & Expanding Capacities
Time: 9:00 am
day: Conference Day One pt 1
Details:
• Showcasing a one-stop discovery services platform to accelerate candidate selection, including mab/protein generation, payload linker synthesis, conjugate generation and in vitro, and in vivo characterisation
• Demonstrating fully integrated ADC CMC development with industry-leading DNA to IND timeline of 13-15 months; mAb/payload linker/conjugation DS & DP development and manufacturing all by in-house team and facilities
• Sharing insight into the rapidly expanding capacities for all ADC component manufacturing: to have five conjugations, four ADC DP facilities by mid-2026 in Wuxi city and Singapore, as well as a global network of mAb facilities and multiple linker-payload facilities
